JAN 13, 2022 9:00 AM PST

Discovering the FDA-cleared Acuitas AMR Gene Panel: Building a Case for Clinical Utility

Sponsored by: OpGen
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Associate Professor of Pathology - Johns Hopkins University School of Medicine and Director of the Medical Bacteriology and Infectious Disease Sequencing Laboratories - Johns Hopkins Hospital
    BIOGRAPHY
  • Associate Medical Director - Clinical Microbiology Laboratories at Beth Israel Deaconess Medical Center / Associate Professor of Pathology at Harvard Medical School
    BIOGRAPHY

Abstract
Date:  January 13, 2022
Time: 9:00am (PST),  12:00pm (EST)
 
Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug-resistant organisms. The guidance highlighted the need to define mechanisms of antimicrobial resistance (AMR) to guide and tailor therapy. In this presentation, we will describe the newly FDA-cleared Acuitas AMR Gene Panel and review the multicenter diagnostic clinical trial data. The Acuitas AMR Gene Panel is a qualitative, multiplex nucleic acid‐based in vitro diagnostic test for detection and differentiation of 28 AMR markers associated with not susceptible results (i.e., intermediate or resistant) to one or more antimicrobial agents among cultured isolates of Enterobacterales, Pseudomonas aeruginosa, and Enterococcus faecalis. The Acuitas AMR Gene Panel has the potential to fill the gap that other rapid molecular tools cannot by detecting a broad array of molecular markers associated with up to 9 classes/subclasses of antimicrobials. The clinical utility of the diagnostic will be presented through a case-based format.
 
Learning Objectives
  • Describe the FDA-cleared Acuitas AMR Gene Panel.
  • Define the performance characteristics of the Acuitas AMR Gene panel.
  • Discover the potential utility of the Acuitas AMR Gene panel to impact patient care.
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
FEB 15, 2023 7:00 AM PST
FEB 15, 2023 7:00 AM PST
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
SEP 28, 2022 9:00 AM PDT
SEP 28, 2022 9:00 AM PDT
Date: September 28, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) While COVID-19 continues to be the most pressing diagnostic focus for clinical laboratories, HIV remains a serious g...
AUG 09, 2022 11:00 AM PDT
AUG 09, 2022 11:00 AM PDT
Date: August 9, 2022 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CEST) Antimicrobial resistance (AMR) has emerged as a major health threat. The FED-AMR project part of the One Health European...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
C.E. CREDITS
Date: October 25, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST) Candida auris is a multi-drug resistant yeast that continues to be a global threat for infection and transmission in h...
OCT 13, 2022 9:00 AM +08
OCT 13, 2022 9:00 AM +08
First Broadcast: Date: October 12, 2022 Time: 8:00am PDT, 11:00am EDT Second Broadcast: Date: October 12, 2022 Time: 9:00am SGT The new Embedded CryoSPARC Live, now fully integrated with t...
Loading Comments...
Show Resources